Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:47
作者
Christiansen, P
Molgaard, C
Müller, J
机构
[1] Rigshosp, Dept Growth & Reprod, Sect GR5064, DK-2100 Copenhagen, Denmark
[2] Danish Vet & Agr Univ, Dept Human Nutr, Frederiksberg, Denmark
[3] Danish Vet & Agr Univ, Ctr Adv Food Studies, Frederiksberg, Denmark
[4] Rigshosp, Juliane Marie Ctr, Paediat Nutr Unit, DK-2100 Copenhagen, Denmark
关键词
bone mineral content; young adults; height; body composition; congenital adrenal hyperplasia;
D O I
10.1159/000075588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess bone mineral content (BMC) and body composition in adolescents and young adults with congenital adrenal hyperplasia. Methods: BMC, anteroposterior-projected bone area ( BA), bone mineral density, and fat mass percentage were determined by dual-energy X-ray absorptiometry in 18 patients aged 18 - 33 years ( 8 females and 10 males) with 21-hydroxylase deficiency using a Hologic QDR 1000/W densitometer. Results: BMC and bone mineral density for age were significantly reduced at - 1.2 standard deviation scores (SDS; range from - 2.8 to + 4.1) and - 1.1 SDS ( range from - 3.2 to + 2.6), respectively. The BA for height was significantly increased at + 1.7 SDS ( range from - 0.5 to + 4.8), and the BMC for BA was normal at 0.3 SDS ( range from - 2.0 to + 3.6). The median final height was significantly reduced at - 1.6 SDS ( range from - 5.6 to + 0.3), and the fat mass percentage was significantly increased at + 1.5 SDS ( range from - 1.0 to + 5.0). Conclusion: Our study population of young adults with 21-hydroxylase deficiency had a short stature and broad bones with a normal BMC and had an increased fat mass percentage. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:133 / 136
页数:4
相关论文
共 24 条
  • [1] Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat
    Abad, V
    Chrousos, GP
    Reynolds, JC
    Nieman, LK
    Hill, SC
    Weinstein, RS
    Leong, GM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) : 1879 - 1885
  • [2] Andersen E, 1982, Ugeskr Laeger, V144, P1760
  • [3] BONE-MINERAL DENSITY AND BODY-COMPOSITION IN CONGENITAL ADRENAL-HYPERPLASIA
    CAMERON, FJ
    KAYMAKCI, B
    BYRT, EA
    EBELING, PR
    WARNE, GL
    WARK, JD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) : 2238 - 2243
  • [4] CARTER DR, 1992, J BONE MINER RES, V7, P137
  • [5] THE EFFECT OF PHARMACOLOGICAL DOSAGES OF GLUCOCORTICOIDS ON FREE-LIVING TOTAL-ENERGY EXPENDITURE IN MAN
    CHONG, PKK
    JUNG, RT
    SCRIMGEOUR, CM
    RENNIE, MJ
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 40 (05) : 577 - 581
  • [6] The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia
    Girgis, R
    Winter, JSD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 3926 - 3929
  • [7] Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia
    Guo, CY
    Weetman, AP
    Eastell, R
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (05) : 535 - 541
  • [8] Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia
    Gussinye, M
    Carrascosa, A
    Potau, N
    Enrubia, M
    VicensCalvet, E
    Ibanez, L
    Yeste, D
    [J]. PEDIATRICS, 1997, 100 (04) : 671 - 674
  • [9] Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy
    Hagenfeldt, K
    Ritzén, EM
    Ringertz, H
    Helleday, J
    Carlström, K
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) : 667 - 671
  • [10] Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency
    Jaaskelainen, J
    Voutilainen, R
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (06) : 707 - 713